Severity N/A
Clorazepate (K) Interaction of Clorazepate (K) with Telithromycin
Phenytoin (Na) Interaction of Phenytoin (Na) with Telithromycin
Details: Phenytoin (Na) is likely to result in subtherapeutic levels of telithromycin and loss of effect.
Carbamazepine Interaction of Carbamazepine with Telithromycin
Details: Carbamazepine is likely to result in subtherapeutic levels of telithromycin and loss of effect.
Phenobarbitone Interaction of Phenobarbitone with Telithromycin
Details: Phenobarbitone is likely to result in subtherapeutic levels of telithromycin and loss of effect.
Digoxin Interaction of Digoxin with Telithromycin
Details: Monitoring of digoxin side effects or serum levels should be considered during concomitant administration of digoxin and Teicoplanin.
Cisapride Interaction of Cisapride with Telithromycin
Details: The use of Teicoplanin is contraindicated with cisapride.
Pimozide Interaction of Pimozide with Telithromycin
Details: There is a potential risk of increased pimozide plasma levels by inhibition of CYP 3A4 pathways by Teicoplanin.
Management: Concurrent use is contraindicated.
Simvastatin Interaction of Simvastatin with Telithromycin
Details: Simvastatin levels were increased by Teicoplanin when used concurrently.
Sunitinib Interaction of Sunitinib with Telithromycin
Details: May increases sunitinib concentrations.
Erlotinib Interaction of Erlotinib with Telithromycin
Details: This CYP3A4 inhibitor increases levels/toxicity of erlotinib
Vemurafenib Interaction of Vemurafenib with Telithromycin
Details: Telithromycin inhibits P-gp, glucuronidation and CYP3A4, and increases plasma concentration of Vemurafenib.
VORICONAZOLE Interaction of VORICONAZOLE with Telithromycin
Details: Voriconazole may increase the serum concentration of telithromycin by decreasing its metabolism.
Management: Monitor for changes in the therapeutic and adverse effects
Ibrutinib Interaction of Ibrutinib with Telithromycin
Details: increased exposure of ibrutinib
Management: co-administration should be avoided
Simeprevir Interaction of Simeprevir with Telithromycin
Details: co- administration increased plasma concentrations of simeprevir
Management: not recommended to co-administered